Pacira BioSciences (NASDAQ: PCRX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Pacira BioSciences (NASDAQ: PCRX) through any online brokerage.
The latest price target for Pacira BioSciences (NASDAQ: PCRX) was reported by Needham on Wednesday, June 15, 2022. The analyst firm set a price target for 76.00 expecting PCRX to rise to within 12 months (a possible 31.81% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Pacira BioSciences (NASDAQ: PCRX) is $57.66 last updated July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for Pacira BioSciences.
Pacira BioSciences’s Q2 earnings are confirmed for Tuesday, August 2, 2022.
There is no upcoming split for Pacira BioSciences.
Pacira BioSciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.